(Q46223001)

English

Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial

scientific article published on 29 November 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

author name string

Roberto Bernabei

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

Roger Bullock

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

Alfonso J Cruz Jentoft

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

Lutz Frölich

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

Christoph Hock

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

Minna Raivio

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

Eric Triau

8

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

Maurits Vandewoude

9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

Anders Wimo

10

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

Elizabeth Came

11

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

Bart Van Baelen

12

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

Gerry L Hammond

13

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

Joop C van Oene

14

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

Susanne Schwalen

15

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

publication date

29 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

Lancet Neurology

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

8

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

39-47

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

Number of dementia sufferers in Europe between the years 2000 and 2050.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Activities of daily living in patients with dementia: clinical relevance, methods of assessment and effects of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient and caregiver characteristics and nursing home placement in patients with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Determinants of costs of care for patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of Alzheimer's disease and other dementias: review of the literature in the light of the findings from the Kungsholmen Project.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Galantamine for Alzheimer's disease and mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Donepezil preserves cognition and global function in patients with severe Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The Test for Severe Impairment: An Instrument for the Assessment of Patients with Severe Cognitive Dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of the nursing home Resident Assessment Instrument in the USA.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Scaling ADLs within the MDS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe impairment battery. A neuropsychological test for severely demented patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Memantine in moderate-to-severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of galantamine in subjects with mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Community-acquired pneumonia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970261-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(08)70261-8

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19042161

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46223001&oldid=2100432787"